Lao Bai Xing Pharmacy and Novartis jointly establish the "Value Pharmacy"

China Securities Journal reports (Journalist Qi Jinzhao) that recently, Xie Zilong, Chairman and President of Lao Baixing (603883) Pharmacy, led a core team to have in-depth discussions with relevant business leaders from Novartis’ China division regarding the transformation and upgrading of retail pharmacies, patient service capability construction, and cooperation planning for 2026. In terms of future strategic cooperation, both parties will focus on upgrading the core service module of “Value Pharmacy,” promoting the acceleration of retail pharmacies’ transformation into professional health service terminals.

Xie Zilong stated that the operational philosophy of Lao Baixing Pharmacy aligns with Novartis’ “Value Retail.” Currently, the company is fully promoting the transition of store terminals from a singular “selling medicine” model to a comprehensive “health management” model, actively building a trustworthy health station at the community level.

Chen Hui, Vice President of Novartis China and Head of Retail, Emerging Markets, and Business, stated that Novartis’ “Value Retail” aims to empower pharmacy pharmacists with professionalism to help establish a patient-centered service system, facilitating the upgrade of retail pharmacies into health stations.

Reportedly, Lao Baixing Pharmacy and Novartis have had a good partnership for many years. In terms of product resources, leveraging Lao Baixing Pharmacy’s network of over ten thousand stores with dedicated areas for original research drugs, multiple original drug products under Novartis reach consumers directly, covering various disease areas such as cardiovascular, renal, oncology, immunology, neuroscience, and ophthalmology, effectively enhancing the accessibility of high-quality original drugs. In terms of chronic disease services, Lao Baixing Pharmacy has established a complete chronic disease health management system. By training chronic disease experts in stores nationwide and utilizing digital technologies to cover disease prevention, monitoring interventions, medication follow-ups, and health guidance, the pharmacy continuously provides warm, high-quality health management services to patients, with cumulative self-testing services for chronic disease management exceeding 130 million visits. Relying on Lao Baixing Pharmacy’s mature chronic disease service system and Novartis’ research and innovation advantages in chronic disease, both parties continue to deepen collaborative implementation. Following Novartis’ “Value Pharmacy” construction standards, over 1,500 Lao Baixing Pharmacies nationwide have been upgraded to “Hypertension Value Pharmacies,” conducting more than 3,000 hypertension mini-classes, and through professional medication guidance, comprehensive chronic disease management, and ongoing health education, they effectively enhance patient service experiences and long-term compliance.

Industry insiders indicate that under the policy positioning of “Health Station,” the core competitiveness of the pharmaceutical retail industry is shifting from traditional drug sales to specialized, scenario-based comprehensive health service capabilities. With the steady advancement of prescription outflow as an industry trend, the deepening cooperation between retail pharmacies and innovative pharmaceutical companies is not only an important path to optimize drug supply and enhance service professionalism but also promotes the industry’s transformation into a community health service hub, better meeting the diverse needs of public health.